Publication Information

{'id': 'https://openalex.org/W3178012928', 'doi': 'https://doi.org/10.1158/1538-7445.am2021-lb144', 'title': 'Abstract LB144: Overexpression of CD47 protects hypoimmune CAR T cells from innate immune cell killing', 'display_name': 'Abstract LB144: Overexpression of CD47 protects hypoimmune CAR T cells from innate immune cell killing', 'publication_year': 2021, 'publication_date': '2021-07-01', 'ids': {'openalex': 'https://openalex.org/W3178012928', 'doi': 'https://doi.org/10.1158/1538-7445.am2021-lb144', 'mag': '3178012928'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2021-lb144', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5101927716', 'display_name': 'Xiaomeng Hu', 'orcid': 'https://orcid.org/0000-0003-3273-4335'}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Xiaomeng Hu', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113503690', 'display_name': 'Mo A. Dao', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mo Dao', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063958304', 'display_name': 'Kathy White', 'orcid': 'https://orcid.org/0000-0001-5329-0708'}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kathy White', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049029247', 'display_name': 'Ryan Clarke', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ryan Clarke', 'raw_affiliation_strings': ['2Sana Biotechnology Inc., Cambridge, MA;'], 'affiliations': [{'raw_affiliation_string': '2Sana Biotechnology Inc., Cambridge, MA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051185569', 'display_name': 'Sam Landry', 'orcid': 'https://orcid.org/0000-0002-2197-7334'}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sam Landry', 'raw_affiliation_strings': ['3Sana Biotechnology Inc., Cambridge, CA;'], 'affiliations': [{'raw_affiliation_string': '3Sana Biotechnology Inc., Cambridge, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037587552', 'display_name': 'Ron Basco', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ron Basco', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051219496', 'display_name': 'Corie Gattis', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Corie Gattis', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005058389', 'display_name': 'Eleonore Tham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Eleonore Tham', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040439244', 'display_name': 'Emily Luo', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Emily Luo', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110927841', 'display_name': 'Andrew Tucker', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Andrew Tucker', 'raw_affiliation_strings': ['4Sana Biotechnology Inc., Seattle, WA.'], 'affiliations': [{'raw_affiliation_string': '4Sana Biotechnology Inc., Seattle, WA.', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080865082', 'display_name': 'Christopher Bandoro', 'orcid': 'https://orcid.org/0000-0002-7615-4220'}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher Bandoro', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074211831', 'display_name': 'Elaine Chu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elaine Chu', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100606265', 'display_name': 'Jun‐Mo Kim', 'orcid': 'https://orcid.org/0000-0002-6934-398X'}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Junmo Kim', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058234751', 'display_name': 'Chi Young', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chi Young', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026859443', 'display_name': 'William E. Dowdle', 'orcid': 'https://orcid.org/0000-0001-7871-8192'}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'William E. Dowdle', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055769040', 'display_name': 'Edward J. Rebar', 'orcid': 'https://orcid.org/0000-0002-6014-1679'}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Edward J. Rebar', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017207916', 'display_name': 'Terry J. Fry', 'orcid': 'https://orcid.org/0000-0001-8044-5226'}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Terry J. Fry', 'raw_affiliation_strings': ['4Sana Biotechnology Inc., Seattle, WA.'], 'affiliations': [{'raw_affiliation_string': '4Sana Biotechnology Inc., Seattle, WA.', 'institution_ids': ['https://openalex.org/I4210086146']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5040644146', 'display_name': 'Sonja Schrepfer', 'orcid': 'https://orcid.org/0000-0002-7696-6229'}, 'institutions': [{'id': 'https://openalex.org/I4210086146', 'display_name': 'Sana Biotechnology (United States)', 'ror': 'https://ror.org/00n7khb11', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210086146']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sonja Schrepfer', 'raw_affiliation_strings': ['1Sana Biotechnology Inc., San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Sana Biotechnology Inc., San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210086146']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.312, 'has_fulltext': False, 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.471022, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 72, 'max': 76}, 'biblio': {'volume': '81', 'issue': '13_Supplement', 'first_page': 'LB144', 'last_page': 'LB144'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10580', 'display_name': 'Immunotherapy and Immune Responses', 'score': 0.967, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12672', 'display_name': 'Phagocytosis and Immune Regulation', 'score': 0.964, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.62807083}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.5248958}, {'id': 'https://openalex.org/C2776090121', 'wikidata': 'https://www.wikidata.org/wiki/Q193529', 'display_name': 'T cell', 'level': 3, 'score': 0.5241542}, {'id': 'https://openalex.org/C136449434', 'wikidata': 'https://www.wikidata.org/wiki/Q428253', 'display_name': 'Innate immune system', 'level': 3, 'score': 0.49394113}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.49102068}, {'id': 'https://openalex.org/C193419808', 'wikidata': 'https://www.wikidata.org/wiki/Q1645075', 'display_name': 'Acquired immune system', 'level': 3, 'score': 0.44981012}, {'id': 'https://openalex.org/C39347974', 'wikidata': 'https://www.wikidata.org/wiki/Q21135811', 'display_name': 'CD40', 'level': 4, 'score': 0.42871755}, {'id': 'https://openalex.org/C67662055', 'wikidata': 'https://www.wikidata.org/wiki/Q1047791', 'display_name': 'Antigen-presenting cell', 'level': 4, 'score': 0.4196092}, {'id': 'https://openalex.org/C129374314', 'wikidata': 'https://www.wikidata.org/wiki/Q909381', 'display_name': 'Interleukin 21', 'level': 4, 'score': 0.41272387}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.35790014}, {'id': 'https://openalex.org/C154317977', 'wikidata': 'https://www.wikidata.org/wiki/Q376266', 'display_name': 'Cytotoxic T cell', 'level': 3, 'score': 0.31973487}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.14100474}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2021-lb144', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.62}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W766574906', 'https://openalex.org/W4225914417', 'https://openalex.org/W3030144597', 'https://openalex.org/W2498374562', 'https://openalex.org/W2257930088', 'https://openalex.org/W2135436588', 'https://openalex.org/W2051218772', 'https://openalex.org/W2050558417', 'https://openalex.org/W2002809032', 'https://openalex.org/W1551592253'], 'abstract_inverted_index': {'Abstract': [0], 'Off-the-shelf': [1], 'CAR': [2, 49, 129, 231, 273, 310, 368, 375, 383, 403, 424, 473], 'T': [3, 23, 41, 50, 98, 130, 140, 168, 193, 199, 206, 232, 274, 311, 336, 340, 369, 376, 384, 404, 425, 474], 'cells': [4, 42, 51, 99, 131, 141, 169, 194, 202, 207, 233, 275, 341, 358, 385, 405, 475], 'could': [5, 299, 400, 415], 'offer': [6], 'advantages': [7], 'over': [8], 'autologous': [9], 'strategies,': [10], 'including': [11], 'ease': [12], 'of': [13, 19, 47, 56, 125, 175, 255, 286, 296, 324, 334, 365, 469, 484], 'manufacturing,': [14], 'quality': [15], 'control': [16], 'and': [17, 22, 45, 52, 84, 94, 111, 116, 157, 159, 165, 200, 216, 237, 242, 261, 279, 355, 397, 497], 'avoidance': [18], 'malignant': [20], 'contamination': [21], 'cell': [24, 83, 222, 236, 263, 281, 350, 370, 479], 'dysfunction.': [25], 'TCR': [26, 158, 326], 'editing': [27], 'can': [28, 67, 79], 'effectively': [29], 'prevent': [30], 'graft-versus-host': [31], 'reactions.': [32], 'However,': [33], 'the': [34, 54, 123, 210, 253, 271, 284, 325, 331, 347, 485], 'vigorous': [35], 'host-versus-graft': [36], 'immune': [37, 71, 127, 196, 221, 292, 388, 478], 'response': [38], 'against': [39, 268], 'histoincompatible': [40], 'prevents': [43], 'expansion': [44], 'persistence': [46], 'allogeneic': [48, 185, 391], 'mitigates': [53], 'efficacy': [55], 'this': [57], 'approach.': [58], 'A': [59, 265], 'major': [60], 'challenge': [61], 'is': [62, 75, 118, 407], 'that,': [63], 'while': [64], 'HLA': [65], 'deletion': [66], 'result': [68], 'in': [69, 240, 243, 346, 353, 359, 390], 'adaptive': [70], 'evasion,': [72], 'innate': [73, 291, 477], 'reactivity': [74], 'enhanced.': [76], 'CD47': [77, 117, 164, 226, 246, 256, 269, 287, 297, 315, 414, 470], 'overexpression': [78, 174, 227, 288, 316], 'block': [80], 'both': [81], 'NK': [82, 235, 262, 280], 'macrophage': [85, 238, 260, 278], 'killing': [86, 239, 480], '(J': [87], 'Exp': [88], 'Med': [89], '(2021)': [90], '218': [91], '(3):': [92], 'e20200839),': [93], 'we': [95], 'hypothesized': [96], 'that': [97, 225, 381, 406], 'would': [100], 'lose': [101], 'their': [102, 343], 'immunogenicity': [103], 'when': [104], 'human': [105, 126, 212], 'leukocyte': [106], 'antigen': [107], '(HLA)': [108], 'class': [109], 'I': [110], 'II': [112], 'genes': [113], 'are': [114, 386], 'inactivated': [115], 'over-expressed.': [119], 'We': [120], 'describe': [121], 'here': [122], 'engineering': [124], 'evasive': [128, 389], 'based': [132], 'on': [133, 330], 'our': [134, 308, 422], 'previously': [135], 'described': [136], 'hypoimmune': [137, 320, 472], 'technology.': [138], 'Human': [139], 'from': [142, 209, 234, 259, 476], 'healthy': [143], 'donors': [144], 'were': [145, 170, 249], 'obtained': [146], 'by': [147, 198], 'leukapheresis.': [148], 'CRISPR/Cas9': [149], 'technology': [150], 'was': [151], 'used': [152], 'to': [153, 162, 204, 251, 277, 289, 373, 409], 'delete': [154], 'b2m,': [155], 'CIITA,': [156], 'lentiviral': [160], 'transduction': [161], 'overexpress': [163], 'CD19CAR.': [166], 'Control': [167], 'unmanipulated': [171], 'except': [172], 'for': [173, 257, 307, 421, 488], 'CD19CAR': [176], 'containing': [177], 'a': [178, 304, 363], '41BB': [179], 'costimulatory': [180], 'domain.': [181], 'When': [182], 'transplanted': [183], 'into': [184], 'humanized': [186], 'mice,': [187], 'hypoimmunogenic': [188, 272, 309, 382, 423], 'HLA-I/II-': [189], 'TCR-': [190], 'CD47+': [191], 'CD19CAR+': [192, 205], 'evade': [195, 290], 'recognition': [197], 'B': [201, 349], 'compared': [203], 'generated': [208], 'same': [211], 'donor': [213], 'using': [214], 'ELISPOT': [215], 'flow': [217], 'cytometry': [218], 'analysis.': [219], 'Innate': [220], 'assays': [223], 'show': [224, 380], 'protects': [228, 471], 'HLA-I/II': [229], 'deficient': [230], 'vitro': [241, 354], 'vivo.': [244], 'Relative': [245], 'expression': [247], 'levels': [248], 'analyzed': [250], 'understand': [252], 'relevance': [254], 'protection': [258], 'killing.': [264], 'blocking': [266, 298], 'antibody': [267], 'made': [270], 'susceptible': [276], 'killing,': [282], 'confirming': [283], 'importance': [285], 'clearance.': [293], 'The': [294], 'use': [295], 'additionally': [300, 416], 'be': [301], 'envisioned': [302], 'as': [303, 418], 'safety': [305, 419], 'strategy': [306, 420], 'cells.': [312, 337, 377, 426], 'Neither': [313], 'isolated': [314], 'nor': [317], 'all': [318], 'three': [319], 'modifications': [321], 'or': [322], 'knockout': [323], 'showed': [327], 'any': [328], 'effect': [329], 'cytotoxic': [332, 394], 'potential': [333], 'CAR+': [335, 339], 'Hypoimmune': [338], 'retain': [342], 'antitumor': [344], 'activity': [345], 'Nalm-6': [348], 'leukemia': [351], 'model': [352], 'clear': [356], 'leukemic': [357], 'NSG': [360], 'mice': [361], 'across': [362], 'range': [364], 'tumor': [366], 'cell:': [367], 'ratios': [371], 'comparable': [372], 'unmodified': [374], 'These': [378], 'findings': [379], 'functionally': [387], 'recipients': [392], 'with': [393], 'anti-tumor': [395], 'capacity': [396], 'suggest': [398], 'they': [399], 'provide': [401], 'universal': [402], 'able': [408], 'persist': [410], 'without': [411], 'immunosuppression.': [412], 'Blocking': [413], 'serve': [417], 'Citation': [427], 'Format:': [428], 'Xiaomeng': [429], 'Hu,': [430], 'Mo': [431], 'Dao,': [432], 'Kathy': [433], 'White,': [434], 'Ryan': [435], 'Clarke,': [436], 'Sam': [437], 'Landry,': [438], 'Ron': [439], 'Basco,': [440], 'Corie': [441], 'Gattis,': [442], 'Eleonore': [443], 'Tham,': [444], 'Emily': [445], 'Luo,': [446], 'Andrew': [447], 'Tucker,': [448], 'Christopher': [449], 'Bandoro,': [450], 'Elaine': [451], 'Chu,': [452], 'Junmo': [453], 'Kim,': [454], 'Chi': [455], 'Young,': [456], 'William': [457], 'E.': [458], 'Dowdle,': [459], 'Edward': [460], 'J.': [461, 464], 'Rebar,': [462], 'Terry': [463], 'Fry,': [465], 'Sonja': [466], 'Schrepfer.': [467], 'Overexpression': [468], '[abstract].': [481], 'In:': [482], 'Proceedings': [483], 'American': [486], 'Association': [487], 'Cancer': [489, 503], 'Research': [490], 'Annual': [491], 'Meeting': [492], '2021;': [493], '2021': [494], 'Apr': [495], '10-15': [496], 'May': [498], '17-21.': [499], 'Philadelphia': [500], '(PA):': [501], 'AACR;': [502], 'Res': [504], '2021;81(13_Suppl):Abstract': [505], 'nr': [506], 'LB144.': [507]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3178012928', 'counts_by_year': [{'year': 2023, 'cited_by_count': 3}], 'updated_date': '2024-12-24T05:47:47.472115', 'created_date': '2021-07-19'}